U.S. Industrial REITs Stock News

Enphase Energy stock has delivered a steep decline of about 75.6% over the past five years, yet current valuation checks suggest the shares now trade close to an intrinsic value estimate from a Discounted Cash Flow (DCF) model and look roughly in line with market multiples rather than clearly cheap or clearly expensive. Over the past five years the share price has fallen about 75.6%, which puts long term holders deep in the red and makes today’s pricing more relevant for new capital than...

From April 1 to July 30, 2026, First Interstate BancSystem repurchased 2,152,356 shares for US$78.04 million, completing its August 2025 buyback program with a total of 8,199,163 shares retired for US$279.60 million. This completion reduces the share count by just over 8%, which can meaningfully alter ownership percentages, capital allocation flexibility, and per-share financial metrics. We’ll now explore how completing this sizeable buyback program fits into First Interstate BancSystem’s...

Choice Hotels International stock has declined by about 18.0% over the past three years, yet its current valuation checks still lean on the cheap side. That combination of weaker medium term returns and a stronger value signal is drawing attention to whether the current share price of US$104.44 reflects what the business is worth. The share price has fallen roughly 18.0% over three years, which suggests investors have been cautious despite more recent periods of positive performance. Recent...

Qorvo stock has climbed over the past year but is still down sharply over five years, while an intrinsic value estimate based on a Discounted Cash Flow (DCF) model points to a premium to the current market price. The broader checks suggest the shares are roughly in line with fair value rather than clearly cheap. Qorvo has declined about 46% over the last 5 years, which puts the recent share price recovery into the context of a long period of weak overall returns. Expectations for Qorvo's...

Ryan Specialty Holdings has delivered a 38.7% gain over the past five years, yet recent share price weakness and a low value score raise questions about how much investors are paying for that track record today. Over five years, the stock is up 38.7%, which is a solid return but not enough on its own to confirm that the current price offers clear value. The launch of Tera Underwriters, targeting insurance for high value data centre hardware used in areas such as AI and cryptocurrency, can...

Capricor Therapeutics reported second-quarter 2026 results on August 13, 2026, with net loss rising to US$40.73 million and basic and diluted loss per share from continuing operations at US$0.70, compared with US$25.91 million and US$0.57 a year earlier. Over the first half of 2026, the company’s net loss widened to US$74.67 million and loss per share to US$1.29, underscoring intensifying cost pressures as it advances its pipeline. We’ll now examine how this widening quarterly net loss...

US inflation data now points to a softer price trend, and markets are watching the Federal Reserve’s next move closely. This kind of macro pause often shifts attention toward individual companies with solid finances that do not rely on economic excitement to create value. That is where High Quality Undervalued Stocks come in. This article highlights three standouts from the screener and explains why they might deserve a closer look. The stocks covered below are just a starting sample, and the...

Teleflex (NYSE:TFX) completed a US$1.5b divestiture of its OEM business, using proceeds for debt reduction and a share repurchase program. The company is pursuing a substantial share buyback alongside balance sheet changes following the OEM transaction. Teleflex received FDA approval for a freeze dried plasma product and reported progress on a drug eluting resorbable scaffold. These moves highlight how some medical technology companies are reshaping their balance sheets while advancing new...

In the past quarter, EZCORP, Inc. reported strong third-quarter fiscal 2026 results, with revenue rising to US$418.75 million and net income to US$38.2 million, while management reiterated an active M&A pipeline across the U.S. and Latin America and a continued focus on disciplined capital allocation. Beyond the headline growth, EZCORP’s move to pursue more acquisitions in markets where it already has local teams and operational experience underscores a preference for expansion that builds...

Suburban Propane Partners (SPH) recently reported third quarter 2026 results, highlighting revenue of US$261.38 million, a wider net loss, and continued seasonal pressure stemming from higher operating costs and reduced propane demand. See our latest analysis for Suburban Propane Partners. Suburban Propane Partners’ latest earnings come after a mixed stretch in the unit price, with the current share price at US$17.75, a 90 day share price return that declined 11.25%, and a 5 year total...

In the past quarter, Century Aluminum Company reported second-quarter 2026 revenue of US$752.1 million, reversing a prior-year loss with net income of US$249.3 million and delivering basic earnings per share of US$2.52 from continuing operations. Alongside this earnings swing, Century Aluminum brought key facilities back to full capacity for the first time in over a decade and advanced its Oklahoma smelter plans under supportive U.S. tariff policy, signaling a materially larger production...

Quantum (QMCO) is in focus after reporting first quarter fiscal 2027 results on August 10, 2026, and issuing revenue guidance for the fiscal second quarter that gives investors an updated view on near term expectations. See our latest analysis for Quantum. Quantum’s recent earnings release and revenue guidance have come alongside a strong shift in sentiment, with the 30 day share price return of 153.5% and 1 year total shareholder return of 245.83% pointing to building momentum despite a weak...

Under Armour stock trades at about US$5.36 after a challenging spell for shareholders, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to the shares looking expensive while market based multiples suggest they may actually be cheap. Under Armour’s share price has declined about 77.1% over the past 5 years, which puts a sharp focus on whether today’s level offers value or reflects deeper business issues. The company’s plan to simplify its product range and support pricing...

Earlier this week, a senior vice president at Allegro MicroSystems sold approximately US$101,000 of company stock, while Benchmark initiated analyst coverage with a positive rating. Together, the insider sale and fresh analyst attention highlight how differing signals from company insiders and external researchers can influence investor perception of Allegro’s outlook. We’ll now examine how Benchmark’s upbeat coverage initiation shapes Allegro MicroSystems’ existing investment narrative and...

NewAmsterdam Pharma earnings jolt investor focus NewAmsterdam Pharma (NasdaqGM:NAMS) moved into the spotlight after its latest earnings report showed second quarter sales of US$3.7 million and a net loss of US$64.14 million, sharpening attention on its financial trajectory. See our latest analysis for NewAmsterdam Pharma. The recent earnings report landed against a weak share price backdrop for NewAmsterdam Pharma, with a 30 day share price return of down 15.63% and a year to date share price...

Millrose Properties stock has returned 5.7% over the past year, yet the broader valuation checks currently lean on the cheap side. This raises the question of whether the recent gains still leave room for further upside in the share price. A 5.7% one year return suggests Millrose Properties has moved up, but not in a way that clearly prices in a stretched valuation. Millrose's commitment to provide up to US$1.25b in capital support for Dream Finders Homes' acquisition plans can support...

In August 2026, Synaptics reported fourth-quarter sales of US$308.0 million and full-year sales of US$1.20 billion, alongside a very large jump in net loss to US$447.4 million for the quarter and US$490.8 million for the year. At the same time, the company completed a share repurchase of 1,402,619 shares for US$99.94 million, highlighting an ongoing capital return program despite the widened losses. We’ll now examine how Synaptics’ sharply higher losses, despite revenue growth, could reshape...

RLX Technology (RLX) is in focus after its Q2 2026 report, which combined 14.8% year over year revenue growth, an earnings miss versus expectations, and confirmation of a Western European acquisition and product expansion beyond e-vapor. See our latest analysis for RLX Technology. Despite the Q2 headlines, RLX Technology’s 1-day share price return declined 3%, with the 30-day share price return down 3.48% and the year to date share price return down 16.38%. The 3-year total shareholder return...

In early August 2026, Victory Capital Holdings reported second-quarter results showing higher revenue of US$435.36 million and net income of US$139.4 million compared with the prior year, while its board maintained a regular quarterly cash dividend of US$0.50 per share and the company completed a significant share buyback tranche. Management also emphasized that the balance sheet and free cash flow support simultaneous reinvestment and shareholder payouts, with acquisition-led expansion...

Arcutis Biotherapeutics recently reported that its chief commercial officer L. Todd Edwards resigned in August to pursue another opportunity, while second-quarter 2026 results showed revenue of US$129.86 million and net income of US$15.01 million, and management raised full-year 2026 net product sales guidance to US$525 million–US$540 million. Alongside the leadership change and stronger earnings, the higher sales outlook highlights how Arcutis’s commercial execution is tracking ahead of its...

Dana stock has posted strong gains over the past few years, yet the current checks still frame it as undervalued on several measures. The recent share price strength now sits alongside a high value score that suggests the broader valuation picture still leans cheap rather than stretched. Over the past 3 years, Dana has delivered a total return of about 107.5%, which puts recent pricing in the context of a multi year rally rather than a short term swing. Future revenue and margin progress may...

Recent revisions to earnings forecasts have put Columbia Financial (CLBK) on investors’ radar. Analysts have aligned around higher expectations for the current quarter and full year, sparking fresh interest in the stock. See our latest analysis for Columbia Financial. Columbia Financial’s recent 1-day share price return of 0.68% extends a strong run, with a 30-day share price return of 17.90% and a year to date share price return of 68.21%. The 1-year total shareholder return of 79.20% points...

Noble stock has delivered very strong returns over the past five years, yet on current checks it does not screen as a clear bargain and instead looks closer to fairly valued. After such a run, investors are weighing whether recent price strength leaves limited room for error or still offers enough support for holding on. Noble has returned 145.4% over the last 5 years, which puts extra focus on whether the current share price already reflects much of the company’s progress. Future valuation...

Alpha and Omega Semiconductor stock has climbed 48.9% year to date, yet its latest valuation checks and recent share price pullback raise questions about how much upside is realistically left. The 48.9% gain so far this year suggests investors have been willing to pay up for Alpha and Omega Semiconductor, which puts more focus on whether current expectations can be supported. Upcoming results, including the market’s focus on gross margins, demand across end markets and inventory levels, may...